BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19060201)

  • 1. NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi.
    Tupin E; Benhnia MR; Kinjo Y; Patsey R; Lena CJ; Haller MC; Caimano MJ; Imamura M; Wong CH; Crotty S; Radolf JD; Sellati TJ; Kronenberg M
    Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19863-8. PubMed ID: 19060201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invariant natural killer T cells act as an extravascular cytotoxic barrier for joint-invading Lyme Borrelia.
    Lee WY; Sanz MJ; Wong CH; Hardy PO; Salman-Dilgimen A; Moriarty TJ; Chaconas G; Marques A; Krawetz R; Mody CH; Kubes P
    Proc Natl Acad Sci U S A; 2014 Sep; 111(38):13936-41. PubMed ID: 25205813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local production of IFN-gamma by invariant NKT cells modulates acute Lyme carditis.
    Olson CM; Bates TC; Izadi H; Radolf JD; Huber SA; Boyson JE; Anguita J
    J Immunol; 2009 Mar; 182(6):3728-34. PubMed ID: 19265151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent arthritis in Borrelia burgdorferi-infected HLA-DR4-positive CD28-negative mice post-antibiotic treatment.
    Iliopoulou BP; Alroy J; Huber BT
    Arthritis Rheum; 2008 Dec; 58(12):3892-901. PubMed ID: 19035513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR alleles determine responsiveness to Borrelia burgdorferi antigens in a mouse model of self-perpetuating arthritis.
    Iliopoulou BP; Guerau-de-Arellano M; Huber BT
    Arthritis Rheum; 2009 Dec; 60(12):3831-40. PubMed ID: 19950279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-4 (IL-4) and IL-13 signaling pathways do not regulate Borrelia burgdorferi-induced arthritis in mice: IgG1 is not required for host control of tissue spirochetes.
    Potter MR; Noben-Trauth N; Weis JH; Teuscher C; Weis JJ
    Infect Immun; 2000 Oct; 68(10):5603-9. PubMed ID: 10992460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice.
    Ma Y; Seiler KP; Eichwald EJ; Weis JH; Teuscher C; Weis JJ
    Infect Immun; 1998 Jan; 66(1):161-8. PubMed ID: 9423853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice lacking CD21 and CD35 proteins mount effective immune responses against Borrelia burgdorferi infection.
    Jacobson AC; Ma Y; Zachary JF; Weis JJ; Weis JH
    Infect Immun; 2007 Apr; 75(4):2075-8. PubMed ID: 17283093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective niche for Borrelia burgdorferi to evade humoral immunity.
    Liang FT; Brown EL; Wang T; Iozzo RV; Fikrig E
    Am J Pathol; 2004 Sep; 165(3):977-85. PubMed ID: 15331421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual role for Fcγ receptors in host defense and disease in Borrelia burgdorferi-infected mice.
    Belperron AA; Liu N; Booth CJ; Bockenstedt LK
    Front Cell Infect Microbiol; 2014; 4():75. PubMed ID: 24967215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine Lyme arthritis development mediated by p38 mitogen-activated protein kinase activity.
    Anguita J; Barthold SW; Persinski R; Hedrick MN; Huy CA; Davis RJ; Flavell RA; Fikrig E
    J Immunol; 2002 Jun; 168(12):6352-7. PubMed ID: 12055252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-Related Differential Stimulation of Immune Response by
    Djokic V; Primus S; Akoolo L; Chakraborti M; Parveen N
    Front Immunol; 2018; 9():2891. PubMed ID: 30619263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of CD4+ CD25+ T cells with prevention of severe destructive arthritis in Borrelia burgdorferi-vaccinated and challenged gamma interferon-deficient mice treated with anti-interleukin-17 antibody.
    Nardelli DT; Burchill MA; England DM; Torrealba J; Callister SM; Schell RF
    Clin Diagn Lab Immunol; 2004 Nov; 11(6):1075-84. PubMed ID: 15539509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody Response to Lyme Disease Spirochetes in the Context of VlsE-Mediated Immune Evasion.
    Rogovskyy AS; Gillis DC; Ionov Y; Gerasimov E; Zelikovsky A
    Infect Immun; 2017 Jan; 85(1):. PubMed ID: 27799330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cells and natural killer T cells in Lyme arthritis.
    Katchar K; Drouin EE; Steere AC
    Arthritis Res Ther; 2013 Nov; 15(6):R183. PubMed ID: 24286535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short report: Association of macrophage inflammatory response and cell death after in vitro Borrelia burgdorferi infection with arthritis resistance.
    Glickstein LJ; Coburn JL
    Am J Trop Med Hyg; 2006 Nov; 75(5):964-7. PubMed ID: 17123997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of Borrelia autoimmunity-induced component of Lyme carditis and arthritis.
    Raveche ES; Schutzer SE; Fernandes H; Bateman H; McCarthy BA; Nickell SP; Cunningham MW
    J Clin Microbiol; 2005 Feb; 43(2):850-6. PubMed ID: 15695691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD28 deficiency exacerbates joint inflammation upon Borrelia burgdorferi infection, resulting in the development of chronic Lyme arthritis.
    Iliopoulou BP; Alroy J; Huber BT
    J Immunol; 2007 Dec; 179(12):8076-82. PubMed ID: 18056348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Classical Complement Pathway Is Required to Control
    Zhi H; Xie J; Skare JT
    Front Immunol; 2018; 9():959. PubMed ID: 29867944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-mediated disease remission in the mouse model of lyme borreliosis.
    Barthold SW; Hodzic E; Tunev S; Feng S
    Infect Immun; 2006 Aug; 74(8):4817-25. PubMed ID: 16861670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.